Core Viewpoint - The beauty industry is expected to maintain steady growth in 2026, driven by product innovation and the rise of domestic brands, with Douyin's beauty GMV projected to grow over 20% year-on-year in January 2026, reflecting a marginal improvement during the off-season due to brand efforts in daily sales and self-broadcasting, alongside the impact of the Spring Festival timing [1][2]. Group 1: Strong Product and Brand Momentum - Companies with strong product and brand momentum are expected to achieve high growth through new product launches and category expansions, such as Ruoyuchen, which is focusing on high-end household cleaning and health products [3]. - Beijiaojie is maintaining stable performance in oral care and is expected to benefit from the trend of AKK ingredients in its probiotic raw material business [3]. - Maogeping is positioned as a high-end brand with ongoing expansion in offline counters and online sales, anticipating rapid growth across multiple product lines [3]. - Linqingxuan is benefiting from the trend of oil-based skincare, with its flagship essence oil performing well and new products showing promise [3]. - Shangmei Co. is expanding its main brand Han Shu and sub-brands, with strong growth expected from key products [3]. Group 2: Leading Brands with Strong Asset Value - Beitanie has been actively adjusting its channel and inventory mechanisms since 2025, leading to product structure upgrades and profit recovery, with strong GMV growth in January 2026 [4]. - Proya is expected to have a clear new product strategy in 2026, launching several key products and expanding its sub-brands to drive steady growth [4]. Investment Recommendations - Companies with strong fundamentals and high growth potential recommended for increased holdings include Ruoyuchen, Beijiaojie, Maogeping, Linqingxuan, and Shangmei Co. [5]. - Companies showing signs of bottom improvement include Beitanie, Proya, Dengkang Oral, Shanghai Jahwa, and Runben Co. [5].

Core Viewpoint - Lin Qingxuan, a high-end domestic skincare brand, aims to become one of the world's top five cosmetics groups by 2025, reflecting a significant shift in the Chinese beauty market towards domestic brands [2][4][8]. Company Overview - Lin Qingxuan is set to go public on the Hong Kong Stock Exchange on December 31, 2025, marking a significant milestone for the company and its founder, Sun Laichun [2]. - The company has experienced a transformation from a struggling domestic brand to a competitive player in the high-end skincare market, with a focus on quality and consumer engagement [5][11]. Market Dynamics - The Chinese beauty market is projected to exceed 1.1 trillion yuan by 2025, with domestic brands capturing 57.37% of the market share, a notable increase from less than 30% two decades ago [8][9]. - The rise of domestic brands is attributed to improved supply chains, research capabilities, and the emergence of new sales channels, particularly e-commerce and live streaming [7][8]. Strategic Goals - Sun Laichun emphasizes the importance of having ambitious goals, stating that Lin Qingxuan's vision is not just to be another domestic brand but to establish itself as a world-class cosmetics group [4][8]. - The company plans to expand its store presence, invest in research and smart manufacturing, and develop a product matrix focused on key categories such as creams, masks, sunscreens, and toners [12]. Consumer Trends - The current consumer base is characterized by a preference for quality over brand loyalty, with a growing number of consumers willing to choose domestic products that meet their standards [9]. - The market is described as a "blue ocean" for mid-range consumers who value product experience, providing an opportunity for domestic high-end brands to thrive [9]. Organizational Development - Post-IPO, Lin Qingxuan will focus on organizational development and brand aesthetics, recognizing that these elements are crucial for achieving global recognition [11]. - The company has initiated collaborations with cultural institutions to enhance its brand narrative and aesthetic appeal [11]. Future Outlook - Lin Qingxuan is actively seeking to expand internationally, with plans to open stores in Southeast Asia, emphasizing brand presence rather than just supply chain expansion [12]. - The founder's philosophy centers on continuous improvement and resilience, viewing challenges as opportunities for growth [12][14].

Group 1: Company Overview - The report highlights that the company Lin Qingxuan has been deeply engaged in the oil-based skincare sector for many years, establishing itself as a pioneer in this field with significant growth potential driven by product expansion and channel development [1][2] - The main brand Lin Qingxuan, founded in 2003, initially focused on natural skincare products and later launched the Camellia Oil Essence in 2014, which has become a leading product in the oil-based skincare category [2][3] - The company has experienced remarkable growth, with revenue and net profit for the first half of 2025 reaching 1.05 billion and 180 million RMB, respectively, representing year-on-year increases of 98% and 110% [2] Group 2: Market Position and Growth Potential - The oil-based skincare market is expected to grow significantly, with a projected market size of 5.3 billion RMB in 2024, reflecting a year-on-year increase of 43% and a compound annual growth rate (CAGR) of 42% from 2019 to 2024 [2][3] - Lin Qingxuan holds a leading market share of 12.4% in the facial oil category, significantly ahead of other brands, thanks to its long-term market education and the popularity of its Camellia Oil Essence [2][3] Group 3: Sales Channels and Performance - The company's star product, the Camellia Oil Essence, has seen rapid sales growth, with revenue from this category increasing by 176% year-on-year in the first half of 2025, accounting for 46% of total revenue [3] - Online sales have surged, with a 137% year-on-year increase in online revenue, which now represents 65% of total sales, driven by the popularity of platforms like Douyin [3] - The company has expanded its offline presence, with over 554 stores as of the first half of 2025, indicating significant potential for further growth in physical retail [3]

Investment Rating - The report gives the company an "Outperform" rating with a target price of 118.57 HKD, corresponding to a 2025 PE of 26x and a reasonable valuation of 149 billion RMB (approximately 166 billion HKD) [1][7]. Core Insights - The company has been deeply engaged in the oil-based skincare sector for many years, leveraging platforms like Douyin to drive the explosive growth of its flagship products. The expansion of product categories and channels is expected to lead to sustained rapid growth [1][7]. - The company has established itself as a leader in the oil-based skincare market, with a significant market share in facial essence oils, projected to reach 12.4% in 2024, significantly ahead of competitors [3][37]. - The financial forecasts indicate substantial revenue growth, with total revenue expected to reach 23.16 billion RMB in 2025, representing a year-on-year increase of 91.5% [2][12]. Company Overview - The company, Lin Qingxuan, was founded in 2003 and has evolved from offering handmade soaps and aloe vera gels to becoming a pioneer in oil-based skincare with its flagship product, Camellia Oil Essence, launched in 2014 [3][17]. - The management team is experienced and stable, with the founder holding over 70% of the shares, ensuring concentrated ownership and strategic direction [22][26]. Business Performance - The flagship product, the Camellia Oil Essence, has seen rapid growth, with revenue from this category increasing by 176% year-on-year in the first half of 2025, accounting for 46% of total revenue [3][28]. - Online sales have surged, with Douyin driving a 137% increase in online revenue in the first half of 2025, contributing to a 65% share of total revenue [3][36]. Industry Insights - The oil-based skincare segment is experiencing high demand, with the market for facial essence oils projected to grow to 5.3 billion RMB in 2024, reflecting a year-on-year increase of 43% [3][37]. - The overall anti-aging skincare market is expected to reach 119.9 billion RMB in 2024, with a significant portion attributed to high-end products [37][39].

Core Viewpoint - Cathay Securities initiates coverage on Lin Qingxuan (02657) with a "Buy" rating, highlighting the company's long-standing focus on oil-based skincare and its potential for sustained rapid growth driven by Douyin and product expansion [1] Group 1: Company Overview - Lin Qingxuan, founded in 2003, initially focused on natural skincare products like handmade soaps and aloe vera gel, and launched its flagship product, camellia oil essence, in 2014, establishing itself as a pioneer in oil-based skincare [1] - The company has a stable and experienced management team, and has recently accelerated its online transformation, with significant growth in revenue and net profit in the first half of 2025, achieving 10.5 million and 1.8 million RMB respectively, representing year-on-year increases of 98% and 110% [1] Group 2: Market Position and Growth Potential - The oil-based skincare segment is experiencing high demand, with the market size projected to reach 5.3 billion RMB in 2024, reflecting a year-on-year growth of 43% and a CAGR of 42% from 2019 to 2024 [2] - Lin Qingxuan has maintained a leading position in the facial essence oil category, holding a 12.4% market share in 2024, significantly ahead of other brands [2] Group 3: Sales and Distribution Channels - The company's flagship product, the camellia oil essence, has seen rapid growth, with revenue from this category increasing by 176% year-on-year in the first half of 2025, accounting for 46% of total revenue [3] - Online sales have surged, with Douyin driving a 137% year-on-year increase in online revenue, which now constitutes 65% of total sales; the company also has over 554 physical stores, indicating substantial room for further expansion [3]

Core Viewpoint - Cathay Securities initiates coverage on Lin Qingxuan (02657) with a "Buy" rating, highlighting the company's long-standing focus on oil-based skincare and the significant growth potential driven by Douyin and product expansion [1] Group 1: Company Overview - Lin Qingxuan, founded in 2003, initially focused on natural skincare products like handmade soaps and aloe vera gel, and launched its flagship product, camellia oil essence, in 2014, establishing itself as a pioneer in oil-based skincare [1] - The company has a stable and experienced management team, and its recent online transformation has led to accelerated growth, with H1 2025 revenue and net profit reaching 1.05 billion and 180 million RMB, respectively, representing year-on-year increases of 98% and 110% [1] Group 2: Market Position - The oil-based skincare segment is experiencing high demand, with the market size projected to reach 5.3 billion RMB in 2024, reflecting a year-on-year growth of 43% and a CAGR of 42% from 2019 to 2024 [2] - Lin Qingxuan has maintained a leading position in the facial essence oil category, holding a 12.4% market share in 2024, significantly ahead of other brands [2] Group 3: Growth Drivers - The company's flagship product, the camellia oil essence, has seen rapid growth, with H1 2025 revenue from this category increasing by 176%, accounting for 46% of total revenue [3] - Online sales have surged, with H1 2025 online revenue growing by 137%, making up 65% of total revenue, driven by Douyin's influence [3] - The company has a robust offline presence with over 554 stores as of H1 2025, indicating potential for further expansion and increased sales per store [3]

Core Viewpoint - Lin Qingxuan's listing process has raised concerns regarding its reliance on a single product, the synergy between online and offline channels, and the personal focus of founder Sun Laichun [1][4]. Group 1: Company Overview - Lin Qingxuan Biotechnology Co., Ltd. (02657.HK) debuted on the Hong Kong Stock Exchange on December 30, 2025, achieving a first-day increase of 9.3%, with a closing price of 81.05 HKD per share, resulting in a total market capitalization of 11.3 billion HKD [2]. - The company reported revenues of 1.052 billion CNY in the first half of 2025, ranking it tenth among domestic beauty companies [2]. Group 2: Business Transformation - Founded in 2003, Lin Qingxuan initially focused on offline sales through over 300 stores, but the COVID-19 pandemic forced a shift to online sales, which now account for over 60% of revenue [3][5]. - The company has embraced live-streaming e-commerce, with family members, including Sun Laichun, acting as "key opinion leaders" to promote products [4]. Group 3: Financial Performance - Lin Qingxuan's revenue grew from 691 million CNY in 2022 to 1.21 billion CNY in 2024, with net profit recovering from a loss of 5.93 million CNY in 2022 to a profit of 187 million CNY in 2024 [4][5]. - The core product, Camellia Oil Anti-Wrinkle Essence, has consistently contributed around 35% to the company's revenue over the past three years [4]. Group 4: Future Strategy - Sun Laichun indicated plans for a multi-brand strategy to expand product offerings, including targeting younger consumers and developing community beauty service brands [5]. - Lin Qingxuan aims to enhance its online-offline integration (OMO) ecosystem, with plans to increase the number of stores from 366 in 2022 to 506 by 2024 [6][7]. - The company is set to implement a "Double Hundred Strategy" in 2026, focusing on nurturing internal talent and recruiting new graduates [8].

Core Viewpoint - Lin Qingxuan, a high-end skincare company, successfully listed on the Hong Kong Stock Exchange, marking a significant milestone in the domestic beauty industry, with a notable initial stock performance and a market capitalization of HKD 11.3 billion [1][2] Company Overview - Founded in 2003, Lin Qingxuan focuses on "oil-based skincare" and anti-wrinkle products, initially relying heavily on offline sales with over 300 stores nationwide before pivoting to online channels due to the pandemic [2][3] - The company experienced a financial crisis during the pandemic, leading to a strategic shift towards e-commerce and securing multiple rounds of financing to support its growth and eventual listing [2][3] Financial Performance - Lin Qingxuan's revenue grew from CNY 6.91 billion in 2022 to CNY 12.1 billion in 2024, with a net profit turnaround from a loss of CNY 5.93 million in 2022 to a profit of CNY 18.7 million in 2024 [3][4] - The company's core product, Camellia Oil Anti-Wrinkle Essence, has consistently contributed around 35% to its revenue over the past three years [3][4] Market Strategy - Lin Qingxuan is expanding its product line and brand strategy, planning to introduce sub-brands targeting younger consumers and community beauty services, while also enhancing the application of Camellia oil in various products [3][4] - The company has successfully integrated online and offline sales channels, with online sales now exceeding offline, and plans to continue expanding its store presence while enhancing service quality [5][6] Management and Organizational Structure - The founder, Sun Laichun, has shifted his role to focus on empowering a younger team, allowing them to take the lead in product development and strategy, which has led to successful product launches like the "Little Gold Pearl" essence [6] - Lin Qingxuan has established two management systems to streamline product development and marketing, aiming to replicate the success of its star products [6]

Core Insights - Lin Qingxuan officially listed on the Hong Kong Stock Exchange on December 30, marking the emergence of the "first domestic high-end skincare stock" in China, indicating a significant shift in the high-end skincare market traditionally dominated by international brands [1][4] - The company aims to enhance its investment in dermatology, botany, and cutting-edge skincare technology while expanding brand building and retail store layout to create exceptional skincare experiences for customers and higher value for shareholders [1] Group 1: Product and Market Performance - Lin Qingxuan's flagship product, Camellia Oil, has established itself as a dominant force in the market, being the only domestic brand among the top 15 high-end skincare brands in China by retail sales in 2024 [5] - The Camellia Oil has maintained its position as the best-selling facial oil in China for 11 consecutive years, with cumulative sales exceeding 45 million bottles by June 30, 2025 [5][6] - The introduction of the new 5.0 Camellia Anti-Wrinkle Repair Oil is expected to further enhance sales performance, with clinical tests showing significant improvements in skin texture and appearance [6][7] Group 2: Financial Growth - Lin Qingxuan's revenue and profit have shown robust growth, with a 93% year-on-year increase in revenue to 1.052 billion yuan and a 120% surge in net profit to 182 million yuan in the first half of 2025 [7] - The contribution of the Camellia Oil category to total revenue is projected to rise from 31.5% in 2022 to 45.5% in the first half of 2025, indicating a clear upward trend [7] Group 3: Future Growth Strategies - Lin Qingxuan is focusing on three new growth strategies: expanding its flagship product matrix, building a multi-brand ecosystem, and exploring global markets [8] - The company plans to launch innovative products like the "Cell Energy Black Gold Cream 2.0" and expand the application of its core ingredients into new beauty and whitening product lines [8] - Lin Qingxuan has initiated its global expansion through Southeast Asia and cross-border e-commerce, creating new market opportunities [9] Group 4: Strategic Partnerships - The company has gained a significant indirect shareholder in L'Oréal, which is expected to enhance Lin Qingxuan's growth strategies by providing access to top-tier research resources and raw material procurement systems [10][11] - L'Oréal's expertise may support Lin Qingxuan's multi-brand strategy and internationalization efforts, ensuring a more stable and far-reaching growth trajectory [11] Group 5: Overall Outlook - The listing is viewed as a new starting point for Lin Qingxuan, with expectations for continued value creation and surprises in the future [12]

Group 1 - Lin Qingxuan officially listed on the Hong Kong Stock Exchange on December 30, with a stock code of 02657.HK, opening at HKD 85 after an IPO price of HKD 77.77, reaching a market capitalization of HKD 12.35 billion on the first day [1] - The company generated significant revenue from its core product, camellia oil, which accounted for nearly 40% of total revenue, with projections indicating it will contribute 45.5% of revenue by the first half of 2025 [1] - Lin Qingxuan's revenue for the first half of 2025 is projected to be HKD 1.052 billion, a substantial increase of 98% year-on-year, with net profit expected to rise by 110.16% to HKD 182 million [1] Group 2 - The IPO raised approximately HKD 997 million, primarily for R&D in skincare technology, brand building, and retail expansion [2] - Notable institutional investors, including Fidelity and Dajia Life, subscribed for about USD 62 million, representing 44.43% of the total shares offered [2] - L'Oréal Group has indirectly become a shareholder in Lin Qingxuan through Shanghai Kaihui Chuangmei, highlighting the brand's significance in the high-end skincare market [3] Group 3 - The listing process took about seven months from the initial filing to the final listing, marking a new phase for Lin Qingxuan in its multi-brand and global expansion strategy [4] - The trend of Chinese beauty brands seeking capital through Hong Kong listings is growing, with other brands like Chando and Proya also filing for IPOs [4]